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Abstract
The role of mitochondria in the control of glutamate excitotoxicity is investigated. The response of cultured cerebellar
granule cells to continuous glutamate exposure is characterised by a transient elevation in cytoplasmic free calcium
concentration followed by decay to a plateau as NMDA receptors partially inactivate. After a variable latent period, a
secondary, irreversible increase in calcium occurs (delayed calcium deregulation, DCD) which precedes and predicts
subsequent cell death. DCD is not controlled by mitochondrial ATP synthesis since it is unchanged in the presence of the
ATP synthase inhibitor oligomycin in cells with active glycolysis. However, mitochondrial depolarisation (and hence
inhibition of mitochondrial calcium accumulation) without parallel ATP depletion (oligomycin plus either rotenone or
antimycin A) strongly protects the cells against DCD. Glutamate exposure is associated with an increase in the generation of
superoxide anion by the cells, but superoxide generation in the absence of mitochondrial calcium accumulation is not
neurotoxic. While it is concluded that mitochondrial calcium accumulation plays a critical role in the induction of DCD we
can find no evidence for the involvement of the mitochondrial permeability transition. ß 1998 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Even in neurones, where the ATP requirement for
ionic homeostasis is particularly high, the safety mar-
gin between cellular ATP supply capacity and de-
mand is considerable as long as glucose and oxygen
are available in excess. However even a brief inter-
ruption in ATP generation, as in transient global
ischaemia, can initiate neurodegeneration, which de-
pending on the severity of the insult can show ne-
crotic or apoptotic characteristics and can occur with
a delay of a few minutes to 1^2 days. Furthermore, a
less severe, but chronic, restriction in neuronal ATP
generation capacity may underlie a range of neuro-
degenerative disorders, including Alzheimer’s, Hun-
tington’s and Parkinson’s diseases, amyotrophic lat-
eral sclerosis and AIDs-related dementia as well as
encephalopathies associated with mitochondrial mu-
tations (reviewed in [1]). The excitatory neurotrans-
mitter glutamate plays a central role in neuronal cell
death associated with these neurodegenerative disor-
ders, and the interaction between the NMDA-selec-
tive glutamate receptor and the mitochondrion forms
the basis of this review, which will focus on necrotic
cell death in neuronal culture.
The sequence of events culminating in excitotoxic
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cell death is initiated by the entry of Ca2 through
predominantly NMDA-selective glutamate receptors
activated by elevated extracellular glutamate. Gluta-
mate is not excitotoxic to anoxic cells as long as
NMDA receptors are inactivated prior to the resto-
ration of oxygen [2]. The two conditions of greatest
risk are ¢rstly the period when circulation is restored
following transient global ischaemia and before the
highly active glutamate transporters can re-accumu-
late the amino acid into neurones and glia, and sec-
ondly in the penumbra surrounding a focal ischaemia
where respiring neurones are exposed to high gluta-
mate concentrations di¡using from the ischaemic
core. This latter region is of particular signi¢cance,
since it demonstrates that glutamate exposure can
destroy the bioenergetic integrity of neurones contin-
uously supplied with glucose and oxygen.
It is convenient to divide the excitotoxic process
into two stages: the initial exposure to glutamate;
and the subsequent ‘latent’ period, where the contin-
ued presence of glutamate is not obligatory and
which culminates in the failure of cytoplasmic Ca2
homeostasis, termed by Tymianski ‘delayed Ca2 de-
regulation’ [3] and subsequent cell death (Fig. 1). Our
analysis will focus on neuronal bioenergetics and will
attempt to deconvolute the interactions between mi-
tochondrial ATP synthesis, Ca2 accumulation and
the generation of reactive oxygen species in cultured
neurones exposed to excitotoxic concentrations of
glutamate.
2. The initial glutamate exposure
In primary neuronal culture, the excitotoxic cas-
cade can be initiated by as little as 5 min exposure
to high glutamate concentrations in the absence of
Mg2 (to prevent voltage-dependent block of the
NMDA receptor). There is overwhelming evidence
that the entry of Ca2 into the cells predominantly
through NMDA-selective glutamate receptors during
this period triggers the subsequent neurodegenera-
tion; however Ca2 loading via voltage-activated
Ca2 channels during KCl-depolarisation is much
less excitotoxic and the reason for this selectivity is
the subject of current controversy. The possibilities
are that the absolute amount of Ca2 entering
through the NMDA receptor may greatly exceed
that through voltage-activated Ca2 channels [4,5],
or that Ca2 entering through the NMDA receptor
is focussed onto a vulnerable excitotoxic locus within
the cell [3,6].
When determined with high-a⁄nity Ca2 indica-
tors, such as fura-2, little di¡erence is seen in the
apparent elevation in [Ca2]c evoked with glutamate
or KCl [7^9]; however the use of low a⁄nity indica-
tors of free Ca2 capable of reporting far higher
concentrations before saturating has indicated that
glutamate-evoked [Ca2]c elevations may be consid-
erably underestimated and may exceed 5 WM, con-
siderably in excess of levels achieved with KCl-depol-
arisation [7,10].
2.1. Neuronal mitochondria sequester cytoplasmic
[Ca2+]c transients
At the termination of a transient glutamate expo-
sure, [Ca2]c tends to return to baseline as the cation
is sequestered into internal organelles or is extruded
across the plasma membrane. Our early studies with
isolated mitochondria from liver and brain demon-
strated that the activity of the mitochondrial Ca2
Fig. 1. Phases of acute glutamate excitotoxicity. Neurones ex-
posed to glutamate show a transient elevation in cytoplasmic
free Ca2, [Ca2]c. Following this initial response, the signal de-
cays to a plateau as NMDA receptors partially inactivate. The
plateau is maintained for a variable time (‘latent period’) until
a secondary, irreversible, increase in [Ca2]c occurs (delayed
Ca2 deregulation).
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uniporter was highly dependent on the extramito-
chondrial Ca2 concentration, [Ca2]o [11] and ex-
ceeded the activity of the independent mitochondrial
Ca2 e¥ux pathway (coupled to H and Na in liver
and brain, respectively [12]) when [Ca2]o rose above
the ‘set-point’ at which uptake and e¥ux balanced
[13]. Mitochondria would therefore be predicted au-
tomatically to bu¡er [Ca2]c above the set-point and
to release it back into the cytoplasm when [Ca2]c
recovered to below this value (reviewed in [12]). With
a predicted set-point of 0.3^0.5 WM [13] even the
Ca2 transients measured with high-a⁄nity indica-
tors during KCl stimulation rise well above these
values and should therefore be in£uenced by mito-
chondrial Ca2 sequestration. In 1981, we obtained
direct evidence of mitochondrial sequestration of de-
polarisation-evoked Ca2 loads by measuring mito-
chondrial 45Ca2 pools within synaptosomes: Ca2
loading of these intact isolated terminals by KCl-ac-
tivation of voltage-activated Ca2 channels resulted
in the large majority of the accumulated Ca2 being
further transported into the matrix [14,15].
In 1990, Thayer and Miller [16] showed that brief
KCl-mediated depolarisation of dorsal root ganglion
cells was followed by a partial recovery in [Ca2]c to
a plateau which varied from 200 to 600 nM, but was
absent in cells depolarised in the presence of proton-
ophore. This plateau was interpreted to be a conse-
quence of the slow release from the mitochondrion of
Ca2 temporarily accumulated at the peak [Ca2]c.
Addition of the protonophore during the plateau
produced a large transient elevation in [Ca2]c con-
sistent with a rapid release of the mitochondrial pool.
A similar plateau was observed in these cells follow-
ing trains of s 25 action potentials [17]; again the
level of the [Ca2]c plateau during recovery (450^550
nM) correlated well with the set-point predicted for
isolated brain mitochondria [13]. A comparable pro-
tonophore enhancement of the KCl-evoked [Ca2]c
transient and abolition of the subsequent plateau has
also been reported for bullfrog sympathetic neurones
[18]. These results were consistent with earlier mod-
elling with isolated mitochondria [19] and have re-
cently been reproduced in whole-cell patch-clamped
chroma⁄n cells following depolarisation-evoked ac-
tivation of voltage-activated Ca2 channels [20].
In 1990, the group of Duchen [21] also reported
enhanced cytoplasmic Ca2 transients in dorsal root
ganglion cells exposed to a range of metabolic in-
hibitors, including protonophores, cyanide and glu-
cose removal, but noted that these e¡ects could be
a consequence of impaired Ca2 extrusion from
the cells as well as inhibited mitochondrial sequestra-
tion.
In a detailed series of papers, White and Reynolds
[9,22,23] have analysed the pathways of Ca2 remov-
al from the cytoplasm following acute, non-toxic,
glutamate exposure. Restoration of baseline [Ca2]c
following as little as 15 s exposure to 3 WM glutamate
was highly dependent upon both vim and extracel-
lular Na ; thus no recovery occurred during wash-
out of glutamate by a Na- free medium containing
protonophore. Interestingly, when the same Ca2
transient was generated by the combination of high
KCl and veratridine (activating voltage-activated
Ca2 channels and allowing Na entry via voltage-
activated Na channels), recovery of [Ca2]c to
baseline could still occur. This was interpreted as
indicating a fundamental di¡erence in the handling
of glutamate-evoked versus KCl/veratridine-evoked
Ca2 loads. While the reason for this di¡erence
was not directly investigated, a likely explanation
was considered to be a greater uptake of Ca2 into
the cell (and hence the mitochondrion) in the former
condition.
2.2. In situ mitochondrial membrane potential (vim)
during acute Ca2+ loading of neurones
The key parameter determining the energetic status
of mitochondria is the proton-motive force, vp,
across the inner membrane (reviewed in [24]). In
the presence of physiological concentrations of Pi
and Mg2, isolated mitochondria from liver, heart
or brain maintain a total vp of some 220 mV of
which the membrane potential vim comprises 150^
180 mV with a vpH of 30.5 to 31 pH unit contrib-
uting the remaining 30^60 mV [25]. The determina-
tion of both components of vp for in situ mitochon-
dria is exceedingly complex; in collaboration with
Hoek and Williamson [26], we quanti¢ed vp for in
situ hepatocyte mitochondria: vim was determined
from the Nernstian distribution between the cyto-
plasm and matrix of the lipophilic cation TPMP,
while vpH was measured by weak acid distribution;
a value for vp of s 200 mV was consistent with
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isolated mitochondria. Subsequently, we quanti¢ed
the vim component for mitochondria within isolated
nerve terminals arriving at an estimate of 150 mV for
glucose-maintained synaptosomes [27].
Direct determination of the Nernstian gradient be-
tween matrix and cytoplasm by confocal microscopy
is extremely di⁄cult due to the small size of the
mitochondria and the enormous dynamic range re-
quired to quantify a 300-fold gradient. Instead, de-
terminations at the population or single-cell level of
resolution membrane-permeant cationic £uorescent
indicators report their concentration within the mi-
tochondrial matrix either by their £uorescent
quenching (e.g. rhodamine-123 [28^34] or tetrameth-
ylrhodamine esters [35^37]) or by a change in their
emission spectra (e.g. JC-1 [9]). An essential control,
which is not always performed, is to establish that
the signal is not a¡ected by a change in plasma mem-
brane potential, for example high [K] or glutamate
in the absence of external Ca2, see [9,28]. With this
important proviso in mind, £uorescent changes indi-
cative of mitochondrial depolarisation have been re-
ported following acute glutamate exposure of cul-
tured neurones [9,28,30,31,33,34,37], although
particularly with JC-1 the pattern of response can
be complex, with both hyperpolarizing and depola-
rizing responses being detected [9]. The ATP syn-
thase inhibitor oligomycin did not prevent the KCl-
evoked vim decrease [28].
The in£uence of mitochondrial Ca2 loading on
vim is complex and has been analysed in detail
only for isolated mitochondria: in the presence of
excess Pi a single addition of Ca2 causes a transient
depression in both the vim and vpH components of
vp, the extent of which is dependent on the Ca2
concentration [38^40]. When net accumulation of
Ca2 is complete both components of vp are restored
to their initial values. The transient depression in vp
can be su⁄cient to interrupt ATP synthesis or even
to causes reversal of the ATP synthase and hydrol-
ysis of ATP ^ consistent with early observations that
Ca2 accumulation could take precedence over ATP
synthesis [41]. The signi¢cance of phosphate is fre-
quently overlooked: however, the anion is co-accu-
mulated into the matrix in parallel with Ca2 where
it forms an osmotically inactive, but rapidly dissoci-
able, calcium phosphate complex [12]. In the absence
of added Pi, and particularly following depletion of
endogenous Pi by an ADP/glucose/hexokinase trap
[11] the capacity of isolated mitochondria to accumu-
late Ca2 is greatly restricted. Thus, while the same
reversible drop in vp occurs during Ca2 accumula-
tion, the vpH generated by protons extruded by the
respiratory chain is no longer neutralised by Pi accu-
mulation and a progressive build-up of vpH occurs.
This can ultimately result in an equipartition between
the two components: a vp of 220 mV being com-
prised of 110 mV of vim and almost 2 pH units of
transmembrane gradient [42,43]. Finally, induction
of the mitochondrial permeability transition (MPT,
see below) will lead to a collapse in both vim and
vp. It is not yet clear which of the above mechanisms
underlies any decrease in vim in glutamate-exposed
neurones.
2.3. Deconvolution of vim e¡ects on mitochondrial
Ca2+ accumulation and ATP synthesis
In intact cells with maintained in situ metabolism,
Ca2 homeostasis cannot be separated from cellular
metabolism and bioenergetics and should be consid-
ered as part of an integrated picture (Fig. 2). Neuro-
nes are almost entirely dependent on exogenous glu-
cose, and the consequent supply of pyruvate to the
mitochondrion and its subsequent oxidation via the
tricarboxylic acid cycle drives both ATP synthesis
and Ca2 accumulation. Since the two processes
compete for the proton circuit they should be con-
sidered together in an analysis of the e¡ects of cel-
lular Ca2 loading. While Ca2 accumulation by the
mitochondria may a¡ect ATP synthesis, alterations
in ATP synthesis will in turn a¡ect the activity of ion
pumps responsible for removing Ca2 from the cy-
toplasm. An analysis of these interactions is one of
the main goals of our laboratory [31,41].
While protonophore addition has been widely em-
ployed to investigate mitochondrial Ca2 pools in
neurones (see above), the collapse in vim will not
only inhibit mitochondrial Ca2 accumulation and
release the cation into the cytoplasm, but should
also instantaneously reverse the mitochondrial ATP
synthase resulting in rapid hydrolysis of cytoplasmic
ATP [41]. Unless the maximal rate of glycolytic ATP
synthesis comfortably exceeds the cellular ATP de-
mand during Ca2 loading plus the rate of ATP hy-
drolysis by the uncoupled mitochondria, the cells will
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become depleted of ATP and ATP-dependent proc-
esses will be compromised.
We have employed rat cerebellar granule cells as
our experimental model; these cells have a high den-
sity of mitochondria both along their neurites and
packed around the nucleus in the relatively thin an-
nulus of cytoplasm [31]. We initially determined
whether the granule cells showed the same response
to protonophores during KCl-depolarisation as the
dorsal root ganglion cells investigated by Thayer and
Miller [16]. Cerebellar granule cells maintain a
[Ca2]c of 6 100 nM, well below the estimated set-
point for rat brain mitochondria (0.3^0.5 WM [13])
and would thus be predicted to be largely depleted of
Ca2. This was con¢rmed by the failure of protono-
phore addition to initiate a transient release of Ca2
into the cytoplasm. In contrast, addition of protono-
phore during the plateau of [Ca2]c following KCl-
depolarisation resulted in a transient spike in the
fura-2 signal, consistent with release from the mito-
chondrial compartment. When protonophore was
added prior to 50 mM KCl, the size of the depolar-
isation-evoked [Ca2]c spike was greatly enhanced,
consistent with earlier studies [18]. While this could
be interpreted as a direct consequence of a failure of
mitochondrial sequestration, a rapid secondary ele-
vation in [Ca2]c led us to suspect that the protono-
phore was causing a collapse in ATP levels, prevent-
ing Ca2 extrusion from the cells. This depletion was
con¢rmed by analysis of ATP/ADP ratios within the
cells : within 5 min, 2 WM CCCP decreased the ratio
from a control value of s 7 to 6 3 [41]. There is thus
ambiguity as to whether the enhanced cytoplasmic
[Ca2]c response is due a failure of mitochondrial
Ca2 accumulation due to the collapsed vim, or a
failure of Ca2 extrusion from the cell in response to
a lowered ATP/ADP ratio.
Seven-day in vitro granule cells incubated in the
presence of 15 mM glucose do not have a su⁄ciently
active glycolytic pathway to be able to maintain a
high ATP/ADP ratio and low basal cytoplasmic
Ca2 in the presence of protonophore, when glycol-
ysis is required to maintain the cell’s normal func-
tions in the face of the freely reversing mitochondrial
ATP synthase. However, when the ATP synthase is
inhibited by oligomycin, preventing both synthesis
and hydrolysis of ATP by the mitochondria, glycol-
ysis can maintain high ATP/ADP ratios and pro-
longed cytoplasmic Ca2 homeostasis [31,41]. As in
other cells [27,44], the addition of oligomycin causes
a slight hyperpolarisation of the in situ mitochondria
[45] consistent with a ‘state 3^state 4’ transition [24].
Since the entire ATP generation by the cell is glyco-
lytic in the presence of oligomycin experiments can
be designed in which vim can be collapsed, for ex-
ample by the further addition of a mitochondrial
respiratory chain inhibitor, such as rotenone
[31,41], without a priori a¡ecting cellular ATP gen-
eration (Fig. 2).
If accumulation of Ca2 into endoplasmic reticu-
lum is ignored, the change in free Ca2 concentration
reported by a £uorescent probe is the net resultant of
cytoplasmic Ca2 chelation, accumulation and re-
lease from mitochondria and uptake and e¥ux
across the plasma membrane, which in neurones is
due to both the plasma membrane Ca2-ATPase and
Na/Ca2 exchanger [21,46,47]. In view of the evi-
dence discussed above that mitochondria sequester
much of the Ca2 load imposed by KCl depolarisa-
tion, it would be predicted that abolition of the mi-
tochondrial pool would enhance the cytoplasmic
Ca2 transient. This is not, however, what we ob-
serve: KCl-depolarisation of granule cells in the pres-
ence of rotenone plus oligomycin actually produces a
smaller peak [Ca2]c elevation than in the presence of
oligomycin alone [41]. Thus, mitochondrial depolar-
isation by protonophores enhances the KCl-evoked
[Ca2]c transient, while mitochondrial depolarisation
by rotenone plus oligomycin decreases the transient.
The trivial explanation that rotenone might directly
inhibit voltage-activated Ca2 channels was elimi-
nated since when both rotenone and protonophore
were present before KCl-depolarisation, the peak
height was enhanced to the same extent as with
FCCP alone [41]. There are two explanations for
this counter-intuitive result : mitochondrial depolar-
isation must either reduce Ca2 entry via the VACCs
responsible for the initial transient, or Ca2 extrusion
from the cell must be enhanced.
Application of the same protocol to granule cells
exposed to glutamate showed that while oligomycin
did not signi¢cantly a¡ect the peak and initial pla-
teau following maximal stimulation of the NMDA
receptor, the combination of rotenone plus oligomy-
cin to depolarise the mitochondria prior to receptor
activation decreased both the initial [Ca2]c transient
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and the subsequent plateau [31]. In further experi-
ments (Budd and Nicholls, unpublished), we have
con¢rmed that metabolic restriction by the complex
III inhibitor antimycin A, protonophore addition
and inhibition of succinate dehydrogenase by malo-
nate each enhanced Ca2 deregulation following
NMDA receptor activation, while the same inhibi-
tors delayed deregulation in the presence of oligomy-
cin. Thus, as in the case of KCl depolarisation, in-
hibitors which will decrease ATP levels enhance
glutamate-evoked cytoplasmic Ca2 transients, while
removal of the mitochondrial matrix as a Ca2 sink
without depleting ATP result in a decrease in [Ca2]c.
Furthermore, the total 45Ca2 accumulated during
exposure to glutamate was also decreased by rote-
none plus oligomycin [31]; thus mitochondrial depol-
arisation must restrict Ca2 entry into the cell and/or
enhance e¥ux of the cation. The mechanism of this
control is currently being investigated.
One hypothesis is that mitochondria control the
BBABIO 44667 30-7-98
D.G. Nicholls, S.L. Budd / Biochimica et Biophysica Acta 1366 (1998) 97^112102
net Ca2 £ux across the plasma membrane by rapid
changes in ATP availability. ATP depletion of gran-
ule cells by simple protonophore addition enhances
the KCl-evoked peak Ca2 elevation and prevents
the maintenance of a subsequent plateau [21,41].
Glucose depletion greatly enhances the [Ca2]c tran-
sient in dorsal root ganglion cells depolarised with
KCl [21]. Lowered glucose availability, both in the
presence and absence of oligomycin, enhances both
the peak and subsequent plateau fura-2 signal of
granule cells during glutamate exposure (Budd,
Ward and Nicholls, unpublished). However, since
the rationale of our experiments in the presence of
oligomycin has been to eliminate e¡ects of mitochon-
drial ATP synthesis, how could mitochondria with
inhibited ATP synthase activity still in£uence cyto-
plasmic ATP/ADP ratios? The experimental observa-
tion is that glutamate causes an equivalent decrease
in granule cell ATP/ADP ratios in the presence and
absence of oligomycin [31]. One factor which is fre-
quently overlooked is the availability of phosphate
(Pi), which is co-accumulated into the mitochondrial
matrix together with Ca2 [12] and the rapid accu-
mulation of the cation into the mitochondrion fol-
lowing NMDA receptor activation could temporarily
deplete the cytoplasm of Pi, which would in turn
decrease the ATP/ADP ratio which could be main-
tained by glycolysis. Thus it has been observed that
low extracellular Pi decreases ATP levels in cultured
neurones and sensitises cells to glutamate-evoked
death [48].
3. Delayed Ca2+ deregulation
The initial peak in [Ca2]c following glutamate
addition and the subsequent recovery to a plateau
largely re£ects the activation and subsequent partial
desensitisation of the NMDA receptors. Once the
plateau is established, the cytoplasmic free Ca2 of
glutamate-exposed cells can remain relatively low
and stable [49] until a sudden, essentially irreversible,
increase occurs (Fig. 3A). Individual cells survive for
varying periods before this ¢nal Ca2 deregulation
and survival ¢ts a single exponential curve, consistent
with a stochastic process [50]. Continued NMDA
receptor activation is not required during this period,
since transient exposure of neurones to glutamate for
as short a period as 5 min can lead to subsequent cell
death, although prolongation of the glutamate expo-
sure does increase toxicity [3]. Plasma membrane in-
tegrity is initially maintained, since £uorescent
probes are still retained in the cytoplasm. While the
ATP/ADP ratio falls in populations of deregulating
cells [31,51] it has not been possible to determine the
ratio in an individual cell during the process. Thus it
is not easy to determine whether there is an upstream
failure of ATP synthesis or a downstream inhibition
of ATP-dependent ion pumps; for example, the plas-
ma membrane Ca2-ATPase or Na/K-ATPase,
due to proteolytic or oxidative damage.
Deregulation of [Ca2]c in our preparation appears
to be a result of failed e¥ux rather than enhanced
in£ux, since the rise in [Ca2]c is not blocked by a
Fig. 2. Schematic inter-relationships between the NMDA receptor, mitochondrial Ca2 transport and cellular bioenergetics. Mitochon-
dria in granule cells utilize pyruvate to generate vp, synthesize ATP and accumulate Ca2. Ca2 extrusion pathways driven by ATP
(e.g. the Ca2-ATPase) maintain a low [Ca2]c. In each ¢gure, the predicted activity of pathways is represented by the line thickness.
In each scheme, the initial response to NMDA receptor activation is depicted. (A) In the absence of inhibitors, ATP synthesis is pre-
dominantly via the ATP synthase. Ca2 entering the cell during NMDA receptor activation is largely accumulated into the mitochon-
dria. Chronic receptor activation can lead to mitochondrial Ca2 overload. (B) In the presence of oligomycin, glycolysis supports the
total cellular ATP demand. Both ATP synthesis and hydrolysis by the mitochondria are inhibited. The mitochondria still load with
Ca2 and despite the presence of the inhibitor cellular ATP falls and Ca2 homeostasis is lost. Thus Ca2-loading of the mitochondri-
on is excitotoxic by a process independent of the oligomycin-sensitive ATP synthase. (C) The complex I inhibitor rotenone prevents
the respiratory chain from pumping protons. Glycolysis now supplies ATP both for the cell and for the ATP synthase which reverses
to generate a reduced proton gradient. Even in the absence of glutamate, the cell can only maintain a low [Ca2]c for a limited peri-
od. When glutamate is added the reversal of the ATP synthase accelerates as it attempts to compensate for the inward £ux of Ca2
into the matrix and the resulting ATP depletion leads to an immediate loss of cytoplasmic Ca2 homeostasis. (D) The combination
of rotenone plus oligomycin allows the proton gradient to decay preventing mitochondrial Ca2 loading. Cytoplasmic ATP is main-
tained by glycolysis ; the decreased 45Ca2 uptake into the cells, together with the maintained low cytoplasmic Ca2, each demonstrate
that Ca2 in£ux through the NMDA receptor is balanced by e¥ux across the plasma membrane when mitochondria can no longer se-
quester Ca2, due either to a feed-back inhibition of the NMDA receptor or an enhanced Ca2 e¥ux. (E) The protonophore FCCP
collapses cellular ATP by reversal of the ATP synthase.
6
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cocktail of channel inhibitors (Budd and Nicholls,
unpublished), while the rate of Mn2 quenching of
fura-2 £uorescence, indicative of Ca2 entry, does
not increase as cells deregulate [52]. There may how-
ever be a contribution to deregulation from mito-
chondrial dumping of Ca2 into the cytoplasm as a
result of mitochondrial depolarisation and/or the
permeability transition.
3.1. The latent period prior to deregulation
The processes which occur during this intermediate
‘latent’ period culminate in cell death which may
have apoptotic [53,54] necrotic [55^57] or mixed
[51,58,59] characteristics depending on the severity
of the initial insult. Thus, within a culture of cerebel-
lar granule cells transiently exposed to glutamate, a
subpopulation were found to depolarise their mito-
chondria and undergo necrosis, while the surviving
cells subsequently repolarised their mitochondria and
regenerated ATP, but underwent later apoptosis [51].
Apoptosis is out of the scope of this review, however,
while activation of the caspase cascade is a common
¢nal pathway for a range of factors inducing granule
cell apoptosis [60^62], caspase inhibitors are unable
to prevent necrosis [63^66].
3.2. Restricted bioenergetics facilitates delayed Ca2+
deregulation
NMDA receptor activation places a multiple en-
ergy demand upon a neurone. The increased cyto-
plasmic Ca2 and Na concentrations will result in
activation of the plasma membrane Ca2-ATPase
and Na/K-ATPase, respectively. The latter may
be quantitatively more important, since even though
NMDA receptors display some selectivity for Ca2
over Na, the much higher concentration of the lat-
ter ion in the extracellular medium means that the
in£ux of Na may exceed that of Ca2 [67]. How-
ever, glutamate is still excitotoxic in Na-free media
[3]. In addition to these plasma membrane e¡ects, the
peak values of [Ca2]c in excess of 5 WM during
glutamate exposure reported in recent experiments
with low a⁄nity Ca2 indicators [7,10] would be pre-
dicted from isolated mitochondrial studies [40] to
result in such a rapid uptake into the mitochondrial
matrix that vp could be transiently lowered below
the value required for ATP synthesis.
Depletion of cytoplasmic ATP will lead to a cata-
strophic deregulation of [Ca2]c by inhibiting the
plasma membrane Ca2-ATPase and also limiting
the activity of the two ATP-requiring enzymes in
the glycolytic pathway, hexokinase and phosphofruc-
tokinase [68]. In our studies, cultured granule cells
treated with FCCP, rotenone or antimycin A (Fig.
3B) show massive Ca2 deregulation upon exposure
to glutamate [31]. In this condition, glycolysis is re-
quired not only to generate ATP for the activated
plasma membrane ion pumps, but also to supply
the reversed mitochondrial ATP synthase, which at-
tempts to regenerate vp which is lowered by the up-
Fig. 3. Delayed Ca2 deregulation following the addition of glutamate/glycine to rat cerebellar granule cells. (A) Addition of 100 WM
glutamate plus 10 WM glycine to cells results in a stochastic Ca2 deregulation. (B) In the presence of antimycin A to inhibit the respi-
ratory chain, glutamate/glycine addition leads to an immediate deregulation which can be accounted for by insu⁄cient ATP synthesis
(see Fig. 1C). (C) In the presence of oligomycin plus antimycin A to depolarize the mitochondria without collapsing ATP, glutamate/
glycine-evoked Ca2 transients are decreased and no Ca2 deregulation occurs within the timespan of the experiment. Each trace rep-
resents [Ca2]c in an individual cell soma determined with fura-2. For further details see [31].
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take of Ca2 into the matrix. It is evident that these
conditions create an instant ATP de¢cit and imme-
diate failure of cytoplasmic Ca2 homeostasis.
There is an extensive literature demonstrating the
synergistic e¡ect of metabolic restriction upon gluta-
mate excitotoxicity both in vivo, e.g. [69^72], and in
vitro [37,59,73^75]. This synergism can also be ob-
served in in vivo models of neurodegenerative dis-
eases: thus the behavioural and morphological ef-
fects of Huntington’s disease following injection of
or 3-nitropropionate into the striatum can be dimin-
ished by NMDA receptor antagonists [76^78] as can
the motor e¡ects of 1-methyl-4-phenylpyridinium
(MPP) inhibition of mitochondrial complex I in
animal models of Parkinson’s disease [71].
3.3. Delayed Ca2+ deregulation is not causally
dependent upon a failure of oxidative
phosphorylation
While Ca2-deregulation of glutamate-exposed
cultured cerebellar granule cells is an imperfect mod-
el for glutamate excitotoxicity, it does allow some
simple hypotheses to be tested. The ¢rst is that a
failure of mitochondrial ATP synthesis is necessary
and su⁄cient for deregulation. This might be ex-
pected in view of the synergistic e¡ects of energy
restriction and NMDA receptor activation discussed
above, as well as the possibility that mitochondria
might be damaged by excessive Ca2 accumulation
(discussed below). Since granule cells have su⁄-
ciently active glycolysis to maintain Ca2 homeosta-
sis when mitochondrial oxidative phosphorylation is
inhibited from the outset in the presence of oligomy-
cin [41], this hypothesis would predict that glutamate
would not be excitotoxic in the presence of the in-
hibitor. However, no statistically signi¢cant di¡er-
ence is observed in the time or extent of Ca2 dereg-
ulation in granule cells exposed to glutamate in the
presence or absence of the inhibitor [31]. In other
words, delayed Ca2 deregulation occurs in cells
whose mitochondria are polarised, transporting elec-
trons and accumulating Ca2, but are not required to
synthesise (or hydrolyze) ATP. A decline in ATP/
ADP ratio is seen in granule cell populations exposed
to glutamate for 60 min in the presence of oligomy-
cin [31], but it is currently unclear whether this is the
cause or e¡ect of the Ca2 deregulation in individual
cells. A further implication of this ¢nding is that
glycolysis can supply su⁄cient ATP to supply the
cell’s energy requirements even when these are en-
hanced during NMDA receptor activation.
3.4. Delayed Ca2+ deregulation is not causally
dependent upon a failure of glycolysis
The requirement of glycolysis for ATP at two steps
(hexokinase and phosphofructokinase) implies that a
cell whose ATP levels are declining, even transiently,
could su¡er an irreversible collapse as glycolysis be-
comes limiting, exacerbating a further decrease in
ATP. In 1986, we found that synaptosomes showed
an initial enhancement of glycolysis, consistent with
a Pasteur e¡ect, following respiratory inhibition by
rotenone, but that this was followed by a progressive
failure [79]. This glycolytic failure has been subse-
quently analysed in more detail [68] under conditions
where the bioenergetic safety margin was eroded by
increased energy demand (e.g. ionophore addition)
and inhibited ATP generation (including rotenone
addition). It was concluded that the ATP require-
ment for hexokinase was the limiting factor during
glycolytic failure [68]. Interestingly, this raises the
question as to how the neurone restarts glycolysis
on recovery from severe ATP depletion. In this con-
text, it has been demonstrated that lactate, which
accumulates during anoxia, can be utilised by se-
verely ATP-depleted cells, generating pyruvate and
allowing mitochondrial oxidative phosphorylation
to regenerate ATP allowing glycolysis to occur [80].
If delayed Ca2 deregulation occurs in a neurone
at a stage where the capacity of the cell to generate
ATP is insu⁄cient to meet its energy demands, it
might be predicted that an additional substrate sup-
ply might be able, at least temporarily, to rescue
cells. Lactate and pyruvate are e¡ective neuronal
substrates [81,82] and Eimerl and Schramm [83]
have reported that pyruvate plus phosphate added
after glutamate exposure decreases cell death. In re-
cent experiments (Budd, Ward and Nicholls, unpub-
lished), we have found that granule cells incubated in
glucose-free media and maintained by lactate or pyr-
uvate undergo glutamate-evoked delayed Ca2 de-
regulation after a similar delay as cells maintained
by glycolysis. Thus, a time-dependent inhibition of
the glycolytic pathway following glutamate exposure
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is not an inherent component of the delayed Ca2
deregulation observed in our preparation.
3.5. In situ mitochondria undergo progressive
bioenergetic deterioration in glutamate-exposed
cells
A number of key catabolic mitochondrial enzymes
are readily inhibited by oxidative damage, including
pyruvate dehydrogenase [84] and aconitase [85]. The
mitochondrial electron transport chain itself is a fur-
ther potential locus for inhibition since complexes I,
III and IV each exert some control over the rate of
oxygen consumption of isolated brain mitochondria
[86]. There is some disagreement as to the bioener-
getic consequences of partial inhibition of these com-
plexes: by comparing the titration of respiratory
chain inhibitors with intact mitochondria and single
complexes Davey and Clark [86] concluded that the
individual complexes had to be inhibited by at least
60% before signi¢cant e¡ects were observed on mi-
tochondrial respiration and ATP synthesis. However
repopulation of mitochondrially depleted rho-0 cells
with mitochondria from patients with either Parkin-
son’s disease displaying 26% de¢ciency in complex I
activity [87] or Alzheimer’s disease displaying 52%
de¢ciency in complex IV activity [88] both resulted
in a slowed recovery of [Ca2]c following Ca2 loads.
A relatively direct demonstration that in situ mi-
tochondria undergo a progressive deterioration of
bioenergetic function following glutamate exposure
is the ¢nding by Atlante et al. [89] that mitochondria
isolated from glutamate-exposed cerebellar granule
cells display a decrease in state 3 respiration which
was proportional to the time for which the cells had
been exposed to glutamate. After a 5-h exposure, the
subsequently isolated mitochondria displayed no sig-
ni¢cant respiratory control. Inhibited state 3 respira-
tion implies a metabolic or respiratory chain limita-
tion rather than a loss of respiratory control,
although the locus of inhibition was not established
in this study.
3.6. Delayed Ca2+ deregulation may be triggered by
mitochondrial Ca2+ accumulation
The total 45Ca2 accumulated by cortical neurones
[4] or cerebellar granule cells [5] in the presence of
glutamate has been considered to be a reliable pre-
dictor of the extent of subsequent cell death. How-
ever, this has recently been challenged by the report
that NMDA-evoked uptake is still much more toxic
than an equivalent extent of KCl-evoked 45Ca up-
take [6], suggesting that the extreme toxicity of glu-
tamate-evoked Ca2 uptake may be due to the selec-
tive direction of the Ca2 onto an excitotoxic locus
in the close vicinity of the intracellular face of the
NMDA receptor [3]. However, since the mitochon-
drial matrix is the only compartment capable of se-
questering this Ca2, it is of central importance to
establish the role which matrix Ca2 accumulation
plays a role in excitotoxicity.
An additional factor, which has not generally been
considered, is that the initial rate of mitochondrial
Ca2 loading, rather than the absolute amount accu-
mulated may be critical. Thus, low a⁄nity Ca2
probes indicate very large [Ca2]c transients in re-
sponse to glutamate [7,10] which would be predicted
to divert all mitochondrial proton pumping to Ca2
accumulation [12]. Indeed, the net accumulation of
45Ca2 by granule cells is largely complete within
5 min (Budd and Nicholls, unpublished). Addition
of NMDA or glutamate to granule cells in low K
medium in the absence of Mg2 (the usual experi-
mental protocol) depolarises the plasma membrane
[90]; however, glutamate addition to granule cells
predepolarised in high KCl medium has been re-
ported to show much decreased excitotoxicity [34].
Since NMDA receptors partially desensitise during
prolonged depolarisation, this implies that the initial
Ca2 entry in polarised cells may be critical in trig-
gering excitotoxicity. It is notable that no lag can be
detected between an increase in [Ca2]c and [Ca2]m
following NMDA receptor activation, whereas some
lag is apparent for KCl-evoked Ca2 loading [91].
3.7. Glutamate is not excitotoxic to cells maintaining
a high ATP with depolarised mitochondria
In the presence of oligomycin, in situ mitochondria
maintain a high vim and thus retain the ability to
accumulate Ca2. Consistent with this, 45Ca2 is ac-
cumulated in the 20 min following addition of gluta-
mate to the same extent as in the absence of the
inhibitor [31]. As in the case of depolarisation-
evoked Ca2 loading discussed above, inhibition of
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the respiratory chain of oligomycin-treated cells
should collapse vim without a¡ecting ATP synthesis
by glycolysis. Respiratory chain inhibitors under
these conditions will, however, collapse vim and
abolish mitochondrial Ca2 accumulation [31] in ad-
dition to blocking electron transport at de¢ned sites
and thus potentially a¡ecting the generation of reac-
tive oxygen species.
The total accumulation of 45Ca2 within cultured
cerebellar granule cells exposed to glutamate can ap-
proach 20 nmol/Wl of cell volume (equivalent to 20
mM!) before the cells die [5]. The mitochondrion is
the only organelle capable of accumulating such
amounts of Ca2, and loss of the mitochondrial
sink for Ca2 entering via the NMDA receptor
should therefore logically result in a rapid saturation
of cytoplasmic Ca2 chelators and a massive eleva-
tion in [Ca2]c. It was therefore remarkable that
granule cells exposed to glutamate in the presence
oligomycin plus rotenone [31] or antimycin A (Fig.
3C) show a relatively small peak Ca2 elevation,
maintain a low subsequent Ca2 plateau and can
survive for up to 5 h in a Mg2-free medium in the
continuous presence of 100 WM glutamate, 10 WM
glycine. Any cell death which occurred in the pres-
ence of these two inhibitors was independent of the
presence of glutamate. Thus, mitochondrial Ca2 ac-
cumulation may be an essential stage in the chain of
events associated with glutamate excitotoxicity.
Such a surprising result requires careful controls,
the ¢rst is to investigate the possibility that rotenone
or oligomycin have previously unrecognised direct
inhibitory actions at the NMDA receptor. Oligomy-
cin alone is not neuroprotective [31], while as dis-
cussed above, rotenone addition in the absence of
oligomycin results in immediate glutamate-evoked
Ca2 deregulation [31]. This would actually be pre-
dicted on bioenergetic grounds: inhibition of the res-
piratory chain places a severe demand upon the gly-
colytic capacity of the cell : in addition to the normal
cellular house-keeping functions which require ATP,
respiratory chain inhibition leads to a reversal of the
mitochondrial ATP synthase as glycolytic ATP is
utilised to regenerate vim (Fig. 2).
3.8. Elevated [Ca2+]c is not itself neurotoxic
In this analysis of the role of mitochondria in the
control of glutamate excitotoxicity, it is important to
distinguish between a relatively stable and reversible
elevation in [Ca2]c, which can be a result of en-
hanced in£ux and/or restricted e¥ux from the cell
and the catastrophic and irreversible rise signalling
the onset of Ca2 deregulation. Thus, Khodorov et
al. [92] exposed 7^8 DIV cerebellar granule cell cul-
tures to the combination of antimycin A and oligo-
mycin to depolarise the in situ mitochondria by a
similar mechanism to our earlier experiments [41].
These authors found that the combination of inhib-
itors resulted in a delayed secondary rise in [Ca2]c
after glutamate exposure, in contrast to our ¢ndings
that the same inhibitors decreased both peak and
plateau responses to continuous glutamate [31], lead-
ing them to conclude that ‘mitochondria play a dom-
inant role in the protection against neuronal Ca2
overload induced by excitatory amino acids’ [92].
Apparently opposite ¢ndings with the same prepara-
tion require some comment: the initial recovery fol-
lowed immediately by a secondary rise in [Ca2]c
after glutamate found by Khodorov et al. is very
similar to the time course of [Ca2]c in our cells in
the presence of protonophore, and suggests an en-
ergy limitation; these authors worked at room tem-
perature and employed 5 mM glucose (in contrast to
our 37‡C and 15 mM glucose). Furthermore, no con-
trols were performed with glutamate in the presence
of oligomycin alone to control for ATP depletion
under these conditions where the maximal rate of
glycolytic ATP synthesis and Ca2 extrusion will be
restricted, but NMDA receptor activity will be vir-
tually unchanged. Since di¡erent experimental or cul-
ture conditions will a¡ect the complex balance be-
tween NMDA receptor activity, Ca2 extrusion
capacity, glycolysis and the capacity for mitochon-
drial ATP synthesis, it will clearly not be possible
to separate e¡ects of mitochondrial ATP synthesis
and Ca2 sequestration by using conditions which
deplete ATP as well as depolarizing the mitochon-
dria.
The experiments we performed with rotenone/oli-
gomycin [31] decreased both the mitochondrial Ca2
accumulation and the cytoplasmic [Ca2]c elevations
in response to glutamate. While we interpreted the
neuroprotection a¡orded by this combination to the
abolition of the matrix accumulation, it was possible
that the decreased cytoplasmic [Ca2]c could account
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for the neuroprotection. It is therefore of consider-
able signi¢cance that the increased [Ca2]c and de-
creased matrix Ca2 produced by protonophores in
cultured hippocampal neurones [8], cortical neurones
[93] and an immortalised hippocampal neuronal cell
line [94] is not only not neurotoxic, but a¡ords pro-
tection against glutamate excitotoxicity [8,93,94].
Putting our results together with these, one can con-
clude that mitochondrial Ca2 loading is potentially
excitotoxic, but that elevated cytoplasmic Ca2, while
controlling the extent of mitochondrial Ca2 loading
and signalling delayed Ca2 deregulation, is not re-
sponsible for the intermediate events leading to a
progressive deterioration in cell function.
3.9. The role of mitochondrially initiated oxidative
damage
Glutamate excitotoxicity requires oxygen; thus
hippocampal neurones exposed to glutamate under
hypoxic conditions show no more cell death than
due to hypoxia alone [2]. Additionally, NMDA an-
tagonists, which protect against excitotoxic damage
to cortical neurones following chemical ischaemia,
need only be present during reperfusion [95]; in other
words, the return of oxidative metabolism triggers a
critical period of toxic NMDA receptor activation.
Reoxygenation is associated both with mitochondrial
Ca2 accumulation and the generation of reactive
oxygen species (ROS) and a central question con-
cerns the causal relationships between these two pa-
rameters and the ultimate death of the cell. We wish
to focus on just one aspect of a complex topic,
namely the role of the in situ mitochondrial mem-
brane potential in the generation of potentially toxic
superoxide Oc32  radicals.
The predominant source of Oc32  in most tissues is
the mitochondrial respiratory chain (reviewed in
[96]). Complex III, and in particular the level of re-
duction of ubisemiquinone at the Qp site, has gener-
ally been considered to be the main source of reactive
oxygen species in mitochondria. Thus, with succinate
as substrate, the generation of reactive oxygen spe-
cies by isolated heart mitochondria is relatively high
in state 4, but virtually abolished when ADP is
added and vim decreases to state 3 levels [97,98].
However, in a recent paper, Herrero and Barja [98]
failed to detect peroxide generated during succinate
oxidation by non-synaptic rat brain mitochondria,
but did detect the reactive oxygen species with sub-
strates utilizing complex 1. No decrease in peroxide
production was found following a state 4^state 3
transition; thus it was proposed that complex I could
be a source of reactive oxygen species in state 3.
Continued production of Oc32  in state 3 by isolated
brain mitochondria is also indicated by the study of
Dykens [99], where Ca2 loading of malate/gluta-
mate supplemented mitochondria in the presence of
ADP increased production of highly reactive hydrox-
yl radicals.
Con£icting consequences of in situ mitochondrial
depolarisation have been reported on the generation
of reactive oxygen species in cultured neurones: the
production of hydrogen peroxide detected by di-
chloro£uorescin is inhibited by protonophores
[100], in accordance with results with isolated mito-
chondria [97,101], although the pH sensitivity of the
signal from the oxidised product, dichloro£uorescein,
creates complications during the large cytoplasmic
acidi¢cation produced both by protonophores [102]
and by NMDA receptor activation [102,103].
The non-£uorescent membrane permeant hydro-
ethidine (HEt) is oxidised within neurones to the
£uorescent ethidium cation by Oc32  and has been
widely used to detect the formation of the radical
in a large number of neuronal and non-neuronal
studies [104^108]. Similar studies have been per-
formed with dihydrorhodamine-123 [109], which is
oxidised to cationic rhodamine-123 predominantly
by peroxynitrite [110]. Since both cationic products
are membrane permeant, they will accumulate in the
matrix of polarised mitochondria, even if they were
the product of non-mitochondrial oxidation; thus
they do not automatically signal the site of free rad-
ical production in imaging studies [111]. In addition,
generated ethidium undergoes £uorescent quenching
when accumulated within the mitochondria matrix
and conversely shows a £uorescent dequenching
upon mitochondrial depolarisation [45]. This can be
di⁄cult to separate from the inherent radical-induced
oxidation, particularly in experiments involving glu-
tamate- or protonophore-mediated mitochondrial de-
polarisation. Thus, a number of studies have re-
ported that protonophore treatment of neurones to
depolarise in situ mitochondria causes an enhanced
generation of ROS detected by dihydrorhodamine-
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123 [109] or hydroethidine [104,108], in contrast to
results with isolated mitochondria. We have re-exam-
ined the behaviour of the latter probe in cultured
cerebellar granule cells and found that the £uorescent
yield of the ethidium generated by hydroethidine ox-
idation is enhanced by mitochondrial depolarisation,
consistent with £uorescent dequenching as the mito-
chondria release ethidium and compounded by fur-
ther £uorescent enhancement as the released ethidi-
um binds to non-mitochondrial nucleic acids [45].
This vim sensitivity could be minimised by the use
of very low concentrations of HEt, such that the
ethidium remains bound within the mitochondria
and is not released on depolarisation, or by extrac-
tion and quanti¢cation of the generated ethidium at
the end of the experiment.
With these precautions, we con¢rm reports that
NMDA receptor activation enhances the generation
of Oc32  by granule cells, but ¢nd no enhancement
upon protonophore addition, in agreement with the
above studies using dichloro£uorescin but in contra-
diction to those using dihydrorhodamine-123 or
HEt. It may, therefore, also be necessary to re-exam-
ine the sequence of events discussed in the context on
apoptotic signalling, where a decrease in vim is pro-
posed to initiate an increase in the generation of re-
active oxygen species, since this has been, in part,
based upon experiments using HEt [112].
3.10. The role of the mitochondrial permeability
transition
While a consensus appears to be emerging that the
MPT, which can be readily observed with isolated
mitochondria, occurs in intact cells as an obligatory
component of apoptotic and necrotic neuronal cell
death, we would wish to counsel caution. While there
is evidence in support of an activation of the MPT in
myocardial reperfusion injury [113^115] and during
oxidative [116] and anoxic [117] stress of hepatocytes,
a role in glutamate-evoked neuronal excitotoxicity is
currently more speculative.
Isolated brain mitochondria incubated in the pres-
ence of adenine nucleotides and Pi are able to accu-
mulate large amounts of Ca2 and to maintain a
stable set-point [13]. Cyclosporin A is an e¡ective
inhibitor of the MPT in isolated liver mitochondria
exposed to Ca2 and Pi (reviewed in [118]) but has
been reported to be much less e¡ective against brain
mitochondria [119]. The inhibitor has been employed
in an attempt to identify a role for the MPT in intact
neurones, but while some measure of protection
against glutamate is generally observed [9,36,37]
but see [30], it is likely that it is the ability of the
agent to inhibit calcineurin, rather than the MPT,
which underlies most of the observed e¡ects. Thus,
while Ankarcrona et al. [120] found that cyclosporin
A protected granule cells against both early necrosis
and delayed apoptosis induced by glutamate, a sim-
ilar protection was a¡orded by the more selective
calcineurin inhibitor FK-506, which does not interact
with the mitochondrial permeability transition pore.
Calcineurin inhibition by cyclosporin A has multiple
e¡ects, including an increase in spontaneous action
potential ¢ring [121] and an inhibition of NMDA
receptors [122], while chronic cyclosporin A induces
neuronal apoptosis in cortical cultures [123,124]. In
our experiments, cyclosporin A, the more selective
methylvaline-4-cyclosporin [125] and bongkrekic
acid [126] each only a¡orded a slight delay before
the onset of delayed Ca2 deregulation (Castilho,
Budd and Nicholls, unpublished), although a more
e¡ective protection has been reported for hippocam-
pal neurones [34].
Even if the MPT is an essential stage in both apop-
totic and necrotic cell death, there are many ques-
tions which remain to be answered. Since increasing
excitotoxic stress causes a shift from apoptosis to
necrosis in a single cell preparation [51], this would
suggest that the proportion of mitochondria within a
neurone undergoing the transition might de¢ne the
fate of the cell : a small proportion swelling and re-
leasing the proposed pro-apoptotic factors cyto-
chrome c [127,128] and apoptosis-inducing factor
[112] might initiate apoptosis with the residual mito-
chondria maintaining su⁄cient ATP levels for apop-
tosis to occur, while a more powerful insult would
disrupt the majority of mitochondria and lead to
death by ATP depletion and subsequent necrosis.
However, delayed Ca2 deregulation still occurs in
cells where mitochondria are prevented from synthe-
sizing ATP by oligomycin [31]. Secondly, with iso-
lated mitochondria the MPT occurs within seconds
of Ca2 overload; in contrast delayed Ca2 deregu-
lation can occur hours after a transient glutamate
exposure, when the mitochondria would have un-
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loaded their Ca2. Finally, the MPT as normally
investigated in isolated mitochondria is inhibited by
Mg2, adenine nucleotides and low pH and is di⁄-
cult to see with NAD-linked substrates [129]. The
conditions within the cytoplasm of a glutamate ex-
posed neurone would on each of these counts be
predicted to be resistant to the MPT and it is cur-
rently unclear what factor would induce the transi-
tion in situ.
4. Conclusions
The mechanism of glutamate-induced neuronal ne-
crosis is far from understood. The mitochondrion
occupies centre stage in three roles: as the prime
generator (and possible dissipator) of cellular ATP;
as the main sink for the Ca2 accumulated via the
NMDA receptor and as the major source of poten-
tially excitotoxic reactive oxygen species. These three
roles are all interconnected, and we may have made a
contribution to unravelling the interactions by high-
lighting the role of mitochondrial Ca2 accumula-
tion.
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